Regarding FLT3-ITD AML, one published study has shown that inhibition of autophagy using shRNA targeting ATG12 or ATG5 can significantly reduce cell proliferation in FLT3-ITD cell lines or their tumorigenicity in a mouse model [23]. The gene discussed is ATG5; the disease is acute myeloid leukemia.